{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:49:35Z","timestamp":1778662175064,"version":"3.51.4"},"reference-count":105,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.revmed.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T19:23:36Z","timestamp":1455909816000},"page":"594-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sarco\u00efdose pulmonaire\u00a0: aspects cliniques et modalit\u00e9s th\u00e9rapeutiques"],"prefix":"10.1016","volume":"37","author":[{"given":"Y.","family":"Uzunhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Crockett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Piver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kambouchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.01.010_bib0530","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0535","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0540","first-page":"173","article-title":"Incidence of clinically identified sarcoidosis in a northwest United States population","volume":"13","author":"Reich","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0545","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0550","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0555","first-page":"167","article-title":"Sarcoidosis: a long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0560","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0565","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","article-title":"Heredity in sarcoidosis: a registry-based twin study","volume":"63","author":"Sverrild","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.01.010_bib0570","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0575","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0580","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/ajrccm.150.4.7921471","article-title":"The epidemiology of interstitial lung diseases","volume":"150","author":"Coultas","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0585","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.rmed.2009.03.001","article-title":"Epidemiology of interstitial lung diseases in Greece","volume":"103","author":"Karakatsani","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0590","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0595","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1183\/09031936.00005414","article-title":"Age-related differences in chest radiographic staging of sarcoidosis in Japan","volume":"43","author":"Sawahata","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0600","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0034-1376860","article-title":"Genetics of sarcoidosis","volume":"35","author":"Fischer","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0605","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"L\u00f6fgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0610","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.156.5.9704069","article-title":"HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis","volume":"156","author":"Berlin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0615","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2016.01.010_bib0620","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2016.01.010_bib0625","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(85)90463-2","article-title":"Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86\u00a0patients observed for 10years","volume":"78","author":"Reich","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0630","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0635","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","article-title":"Sex-specific manifestations of L\u00f6fgren's syndrome","volume":"175","author":"Grunewald","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0640","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0645","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0650","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2214\/ajr.131.3.409","article-title":"A reevaluation of intrathoracic lymphadenopathy in sarcoidosis","volume":"131","author":"Bein","year":"1978","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.revmed.2016.01.010_bib0655","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/radiology.169.2.3174979","article-title":"Pulmonary sarcoidosis in the older patient: conventional radiographic features","volume":"169","author":"Conant","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2016.01.010_bib0660","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136\u00a0cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0665","first-page":"130","article-title":"Optimal scoring of serial change on chest radiography in sarcoidosis","volume":"28","author":"Zappala","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0670","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0009-9260(96)80343-6","article-title":"The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study","volume":"51","author":"Gawne-Cain","year":"1996","journal-title":"Clin Radiol"},{"key":"10.1016\/j.revmed.2016.01.010_bib0675","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-008-9118-2","article-title":"The clinical and radiologic features of nodular pulmonary sarcoidosis","volume":"187","author":"Malaisamy","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.revmed.2016.01.010_bib0680","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MD.0b013e3181775a73","article-title":"Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis","volume":"87","author":"Hours","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.01.010_bib0685","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiology.189.3.8234692","article-title":"Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation","volume":"189","author":"Remy-Jardin","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2016.01.010_bib0690","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.revmed.2016.01.010_bib0695","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188\u00a0whole-body fluorodeoxyglucose positron emission tomography scans in 137\u00a0patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0700","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0705","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18\u00a0FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0710","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2016.01.010_bib0715","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1378\/chest.08-2569","article-title":"Airway involvement in sarcoidosis","volume":"136","author":"Polychronopoulos","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0720","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.120.1.109","article-title":"Endobronchial biopsy for sarcoidosis: a prospective study","volume":"120","author":"Shorr","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0725","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2013.5823","article-title":"Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial","volume":"309","author":"Von Bartheld","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2016.01.010_bib0730","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thx.2008.105031","article-title":"Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?","volume":"64","author":"Boer de","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.01.010_bib0735","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0030-1262207","article-title":"Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET","volume":"31","author":"Costabel","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0740","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.43.7.516","article-title":"Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease","volume":"43","author":"Valeyre","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.01.010_bib0745","first-page":"188","article-title":"Diagnostic efficacy of ultrasound-guided core-needle biopsy of peripheral lymph nodes in sarcoidosis","volume":"32","author":"Boussouar","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0750","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1378\/chest.126.5.1423","article-title":"Sarcoidosis diagnosed in elderly subjects: retrospective study of 30\u00a0cases","volume":"126","author":"Chevalet","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0755","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0034-1381229","article-title":"Clinical presentation of sarcoidosis and diagnostic work-up","volume":"35","author":"Valeyre","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0760","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"Bargagli","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2016.01.010_bib0765","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MCP.0000000000000075","article-title":"Advanced pulmonary sarcoidosis","volume":"20","author":"Valeyre","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0770","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0775","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","article-title":"Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients","volume":"107","author":"Baughman","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0780","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.00150609","article-title":"Chronic interstitial pneumonitis in end-stage sarcoidosis","volume":"35","author":"Shigemitsu","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0785","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1378\/chest.130.6.1851","article-title":"Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis","volume":"130","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0790","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","article-title":"Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage","volume":"6","author":"Viskum","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0795","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0012-3692(15)37649-2","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0800","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1378\/chest.127.2.472","article-title":"Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution","volume":"127","author":"Chambellan","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/RCT.0b013e31815b63dd","article-title":"High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction","volume":"32","author":"Naccache","year":"2008","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.revmed.2016.01.010_bib0810","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1378\/chest.116.5.1194","article-title":"Airway obstruction in bronchial sarcoidosis: outcome with treatment","volume":"116","author":"Lavergne","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0815","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/j.lpm.2012.04.003","article-title":"Pulmonary hypertension complicating sarcoidosis","volume":"41","author":"Nunes","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0820","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.11-0324","article-title":"Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988\u00a0to 2007","volume":"140","author":"Swigris","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0825","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.01.010_bib0830","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0835","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0840","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","article-title":"Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation","volume":"39","author":"Shlobin","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0845","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcl038","article-title":"Presenting characteristics as predictors of duration of treatment in sarcoidosis","volume":"99","author":"Baughman","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.01.010_bib0850","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/eci.11.84","article-title":"Therapy for sarcoidosis: evidence-based recommendations","volume":"8","author":"Baughman","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2016.01.010_bib0855","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.01.010_bib0860","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0865","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0870","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0875","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: a systematic review","volume":"287","author":"Paramothayan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2016.01.010_bib0880","first-page":"CD001114","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2016.01.010_bib0885","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.116.2.424","article-title":"Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study","volume":"116","author":"Pietinalho","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0890","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0895","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0900","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis","volume":"38","author":"Sahoo","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0905","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0910","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0915","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0920","first-page":"49","article-title":"C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis","volume":"27","author":"Sweiss","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0925","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0930","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-a G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"Wijnen","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0935","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-\u03b1 inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0940","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2013.11.019","article-title":"The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial","volume":"108","author":"Judson","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0945","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0950","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/WNL.0b013e3181ec7ff9","article-title":"A case of neurosarcoidosis successfully treated with rituximab","volume":"75","author":"Bomprezzi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.01.010_bib0955","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.revmed.2016.01.010_bib0960","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.01.010_bib0965","first-page":"201","article-title":"Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis","volume":"30","author":"Drake","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib0970","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-2600(15)00199-X","article-title":"New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches","volume":"3","author":"Baughman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0975","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MCP.0000000000000194","article-title":"Personalized medicine in sarcoidosis: predict responders and nonresponders","volume":"21","author":"Petrek","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0980","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.125.3.990","article-title":"Sarcoidosis, race, and short-term outcomes following lung transplantation","volume":"125","author":"Shorr","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib0985","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2007-970339","article-title":"Lung transplantation in sarcoidosis","volume":"28","author":"Shah","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0990","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.219.2.r01ma12503","article-title":"Frequency and CT findings of recurrent disease after lung transplantation","volume":"219","author":"Collins","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2016.01.010_bib0995","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1378\/chest.12-2479","article-title":"Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data","volume":"145","author":"Zappala","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib1000","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","article-title":"Acute pulmonary exacerbations of sarcoidosis","volume":"142","author":"Panselinas","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib1005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib1010","first-page":"52","article-title":"The late follow-up of chronic sarcoid patients previously treated with corticosteroids","volume":"15","author":"Rizzato","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib1015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib1020","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.01.010_bib1025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.121.1.32","article-title":"Mortality of intrathoracic sarcoidosis in referral vs population-based settings*: influence of stage, ethnicity, and corticosteroid therapy","volume":"121","author":"Reich","year":"2002","journal-title":"Chest J"},{"key":"10.1016\/j.revmed.2016.01.010_bib1030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988\u00a0to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib1035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib1040","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.01.010_bib1045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.01.010_bib0525","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(13)70290-X","article-title":"An algorithm to predict survival in pulmonary sarcoidosis","volume":"2","author":"Valeyre","year":"2014","journal-title":"Lancet Respir Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:49Z","timestamp":1759336609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0248866316000412"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.01.010","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarco\u00efdose pulmonaire\u00a0: aspects cliniques et modalit\u00e9s th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}